{"DataElement":{"publicId":"2787906","version":"1","preferredName":"Person Clinical Trial CLL Response Stratification Type","preferredDefinition":"The tumor response type of a person a with chronic lymphocytic leukemia, the most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States, as criteria for participating in the type of research study that tests how well new medical treatments or other interventions work in people.","longName":"3230379v1.0:2787905v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"3230379","version":"1","preferredName":"Person Clinical Trial CLL Response Stratification","preferredDefinition":"information relating to the process of classifying patients by response (any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent) participating in the type of research study that tests how well new medical treatments or other interventions work in people with chronic lymphocytic leukemia, the most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.","longName":"2236731v1.0:3230377v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3230377","version":"1","preferredName":"Clinical Trial CLL Response Stratification","preferredDefinition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical study.:The most common type of chronic lymphoid leukemia, and comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  The clinical course is indolent, but this type of leukemia is not considered to be curable with available therapy. (WHO, 2001) -- 2003:Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.:The process of classifying patients into strata as part of the randomization process or for purposes of data analysis.","longName":"C15207:C3163:C25755:C25689","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Trial","conceptCode":"C15207","definition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Chronic Lymphocytic Leukemia","conceptCode":"C3163","definition":"The most common type of chronic lymphoid leukemia.  It comprises 90% of chronic lymphoid leukemias in the United States.  Morphologically, the neoplastic cells are small, round B-lymphocytes.  This type of leukemia is not considered to be curable with available therapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stratification","conceptCode":"C25689","definition":"The process of classifying patients into a sequence of grades or ranks as part of the randomization process or for purposes of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C0728F-A34C-F16F-E040-BB89AD4349AC","latestVersionIndicator":"Yes","beginDate":"2011-04-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-25","modifiedBy":"ONEDATA","dateModified":"2011-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A1C0728F-A35D-F16F-E040-BB89AD4349AC","latestVersionIndicator":"Yes","beginDate":"2011-04-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-04-25","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2787905","version":"1","preferredName":"CML Response Stratification Type","preferredDefinition":"the protocol stratification factors based on CML response.","longName":"CML_RESP_STRAT_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Confirmed CR","valueDescription":"Complete Response, Confirmed","ValueMeaning":{"publicId":"2677065","version":"1","preferredName":"Complete Response, Confirmed","longName":"2677065","preferredDefinition":"Having been established or verified.: The disappearance of all signs of cancer in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complete Remission","conceptCode":"C4870","definition":"The disappearance of all signs of cancer in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39644D6E-B5DD-21D7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-05","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-05","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":"User created long name for DCI, Modified RANO, ghd, 04.24.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"57CE2826-774A-150D-E044-0003BA3F9857","beginDate":"2008-09-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-26","modifiedBy":"ONEDATA","dateModified":"2008-09-26","deletedIndicator":"No"},{"value":"nPR","valueDescription":"Nodular Partial Remission","ValueMeaning":{"publicId":"2724515","version":"1","preferredName":"Nodular Partial Remission","longName":"2724515","preferredDefinition":"Remission with persistent lymphoid nodules in the bone marrow","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nodular Partial Remission","conceptCode":"C70633","definition":"Remission with persistent lymphoid nodules in the bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4450D85F-4EF5-43BF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ALEYR","dateCreated":"2008-01-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"57CE2826-775C-150D-E044-0003BA3F9857","beginDate":"2008-09-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-26","modifiedBy":"ONEDATA","dateModified":"2008-09-26","deletedIndicator":"No"},{"value":"PR","valueDescription":"Partial Response","ValueMeaning":{"publicId":"2559721","version":"1","preferredName":"Partial Response","longName":"2559721","preferredDefinition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Partial Response","conceptCode":"C18212","definition":"A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B656-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2023-09-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"57CE2826-7768-150D-E044-0003BA3F9857","beginDate":"2008-09-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-26","modifiedBy":"ONEDATA","dateModified":"2008-09-26","deletedIndicator":"No"},{"value":"SD or PD","valueDescription":"Stable Disease PD","ValueMeaning":{"publicId":"2787907","version":"1","preferredName":"Stable Disease PD","longName":"2787907","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.: Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57CE3B4C-1857-1EDD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"57CE3B4C-1870-1EDD-E044-0003BA3F9857","beginDate":"2008-09-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-26","modifiedBy":"SHIDED","dateModified":"2008-09-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"57CE00FE-CAF3-025C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-26","modifiedBy":"HARTLEYG","dateModified":"2018-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"CLL Response Assessment","type":"Preferred Question Text","description":"CLL Response Assessment","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"57CE01FC-5F6E-0DB6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2008-09-26","modifiedBy":"CAMPBELB","dateModified":"2011-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}